Clinical Trials Search Results
Results 1-10 of 332 for your search
Show Search Criteria
Your Search Criteria
Category |
Your Selection |
|---|---|
| Keywords/Phrases: | "colorectal cancer" |
Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 1189 locations
Age: 18 years and over
Gender: Male or Female
Location: 1189 locations
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 828 locations
Age: 18 years and over
Gender: Male or Female
Location: 828 locations
Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 904 locations
Age: 18 years and over
Gender: Male or Female
Location: 904 locations
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients with Locally Advanced or Metastatic HER2 / Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 631 locations
Age: 18 years and over
Gender: Male or Female
Location: 631 locations
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient with Locally Advanced Rectal Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 580 locations
Age: 18 years and over
Gender: Male or Female
Location: 580 locations
Combination Chemotherapy with or without Atezolizumab in Treating Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 778 locations
Age: 18 years and over
Gender: Male or Female
Location: 778 locations
Combination Chemotherapy, Bevacizumab, and / or Atezolizumab in Treating Patients with Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 261 locations
Age: 18 years and over
Gender: Male or Female
Location: 261 locations
Durvalumab and Tremelimumab with or without High or Low-Dose Radiation Therapy in Treating Patients with Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 40 locations
Age: 18 years and over
Gender: Male or Female
Location: 40 locations
PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 41 locations
Age: 18 years and over
Gender: Male or Female
Location: 41 locations
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Active
Age: 18 years and over
Gender: Female
Location: 40 locations
Age: 18 years and over
Gender: Female
Location: 40 locations